Table 1.
Author | Year | Period | Pts | Mean follow-up (yrs) | Persistent HPT (%) | Recurrent HPT (%) | Hypoparathyroidism (%) |
Edis et al. (23) | 1979 | 1959–76 | 55 | 3.9 | 13 | 0 | 35 |
Prinz et al. (24) | 1981 | 1955–76 | 12 | 9.5 | 33 | 0 | 25 |
Van Heerden et al. (25) | 1983 | 1960–83 | 45 | N.A. | 6.6 | 6.6 | 13 |
Goretzki et al. (26) | 1991 | 1986–90 | 18 | N.A. | 11 | 0 | 0 |
Hellman et al. (17) | 1992 | 1982–91 | 11 | 11.9 | 0 | 27.3 | 27.3 |
Kraimps et al. (5) | 1992 | 1966–88 | 14 | 8 | 14 | 36 | 10 |
O' Riordain et al. (15) | 1993 | 1970–91 | 54 | 10 | 0 | 16.4*) | 8 |
Janson et al. (18) | 1994 | 1971–92 | 4 | 9.9 | 0 | 25 | 0 |
Thompson et al. (27) | 1994 | 1972–92 | 14 | 20 | 7 | 7 | 0 |
Grant at al. (28) | 1994 | 1980–93 | 15 | 4.7 | 0 | 13.3 | 0 |
Nilsson et al. (19) | 1994 | 1971–92 | 2 | 9 | 0 | 0 | 0 |
Hellman et al. (20) | 1998 | 1969–96 | 9 | 7.3 | 22 | 44 | 0 |
Goudet et al. (14) | 2001 | 1986–97 | 73 | N.A. | 16.8 | N.A. | N.A. |
Dotzenrath et al. (21) | 2001 | 1986–98 | 25 | 10 | N.A. | 8*) | 12 |
Arnalsteen et al. (4) | 2002 | 1992–01 | 66 | 10 | N.A. | 33*) | 12.7 |
Elaraj et al. (22) | 2003 | 1960–02 | 63 | 10 | N.A. | 51*) | 26 |
Hubbard et al. (29) | 2006 | 1974–02 | 21 | 5 | 0 | 5 | 10 |
Norton et al. (13) | 2008 | 1970–05 | 41 | 7.9 | 12 | 44 | 10 |
Actuarial estimation.
N.A. = not applicable.